Related Experiment Video
Updated: Mar 13, 2026
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
The Tumor Microenvironment as a Barrier to Cancer Nanotherapy
Louis T Curtis1, Hermann B Frieboes2
1Department of Bioengineering, University of Louisville, Lutz Hall 419, Louisville, KY, 40292, USA.
Abstract:
Although extensive research effort and resources have been dedicated to the development of nanotherapeutics to treat cancer, few formulations have reached clinical application. A major reason is that the large number of parameters available to tune nanotherapy characteristics coupled with the variability in tumor tissue precludes evaluation of complex interactions through experimentation alone. In order to optimize the nanotechnology design and gain further insight into these phenomena, mathematical modeling and computational simulation have been applied to complement empirical work. In this chapter, we discuss modeling work related to nanotherapy and the tumor microenvironment. We first summarize the biology underlying the dysregulated tumor microenvironment, followed by a description of major nano-scale parameters. We then present an overview of the mathematical modeling of cancer nanotherapy, including evaluation of nanotherapy in multi-dimensional tumor tissue, coupling of nanotherapy with vascular flow, modeling of nanotherapy in combination with in vivo imaging, modeling of nanoparticle transport based on in vitro data, modeling of vasculature-bound nanoparticles, evaluation of nanotherapy using pharmacokinetic modeling, and modeling of nano-based hyperthermia. We conclude that an even tighter interdisciplinary effort between biological, material, and physical scientists is needed in order to eventually overcome the tumor microenvironment barrier to successful nanotherapy.
Insights
Mathematical modeling and computational simulation are crucial for optimizing cancer nanotherapeutics by analyzing complex interactions within the tumor microenvironment. This approach complements experimental work to overcome barriers to clinical application.
Area of Science:
- Biomedical Engineering
- Computational Biology
- Nanotechnology
Background:
- Extensive research in nanotherapeutics for cancer has yielded limited clinical success.
- Complex interactions between nanotherapy parameters and the variable tumor microenvironment hinder experimental evaluation.
- The tumor microenvironment presents a significant barrier to effective nanomedicine delivery and efficacy.
Purpose of the Study:
- To discuss the role of mathematical modeling and computational simulation in optimizing cancer nanotherapy design.
- To provide an overview of modeling approaches for nanotherapy within the tumor microenvironment.
- To highlight the need for interdisciplinary collaboration to advance nanotherapeutics.
Main Methods:
- Review and discussion of existing mathematical modeling and computational simulation studies.
- Summarization of tumor microenvironment biology and key nano-scale parameters.
- Presentation of various modeling strategies including multi-dimensional tissue evaluation, vascular flow coupling, in vivo imaging integration, in vitro data transport modeling, vasculature-bound nanoparticle simulation, pharmacokinetic analysis, and nano-based hyperthermia modeling.
Main Results:
- Mathematical modeling offers a powerful approach to complement experimental efforts in understanding nanotherapy behavior.
- Various modeling techniques can address specific challenges in nanotherapy delivery and efficacy within the tumor.
- Simulation enables the exploration of complex interactions that are difficult to study solely through experimentation.
Conclusions:
- Mathematical modeling is essential for optimizing nanomedicine design and overcoming tumor microenvironment barriers.
- A significant need exists for enhanced interdisciplinary collaboration among biological, material, and physical scientists.
- Integrated computational and experimental approaches are key to advancing cancer nanotherapeutics towards clinical success.
Related Concept Videos
02:17The Tumor Microenvironment
02:17The Tumor Microenvironment
01:27Tumor Immunotherapy
02:56Treatment Resistant Cancers
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:15Drugs that Stabilize Microtubules